Vindesine a short review of preclinical and first clinical data R. W. DykeR. L. NelsonW. P. Brade ReviewPaper Pages: 229 - 232
Vindesine a clinical trial with special reference to neurological side effects R. ObristU. ParaviciniJ.-P. Obrecht Original Articles Pages: 233 - 237
Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells K. L. KingG. B. Boder Original Articles Pages: 239 - 242
Clinical pharmacokinetics of vindesine R. L. NelsonR. W. DykeM. A. Root Original Articles Pages: 243 - 246
Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas M. BayssasJ. GouveiaG. Mathé Original Articles Pages: 247 - 255
Vindesine as a single agent in the treatment of advanced malignant melanoma S. RetsasK. A. NewtonG. Westbury Original Articles Pages: 257 - 260
Vindesine in the treatment of breast cancer I. E. SmithT. J. Powles Original Articles Pages: 261 - 262
Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors A. Y. BedikianM. ValdiviesoE. J. Freireich Original Articles Pages: 263 - 266
An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood W. KrivitR. ChilcoteD. Hammond Original Articles Pages: 267 - 270
Vindesine a review of phase-II trials R. J. GrallaC. T. C. TanC. W. Young Original Articles Pages: 271 - 274